Buprenorphine Unfiltered: Efficacy, Discontinuation, and Post-Acute Withdrawal

Few medications in addiction treatment generate as much debate as buprenorphine.

After receiving significant listener feedback describing difficult experiences with this medication—particularly around discontinuation—Terri sits down with returning guest Dr. Stuart Gitlow for a candid, science-based discussion about one of the most widely used treatments for opioid use disorder.

In this episode, we explore:

• The science behind medication for opioid use disorder (MOUD)• Why buprenorphine has helped many patients• Reported challenges with tapering and discontinuation• Post-acute withdrawal symptoms (PAWS)• The importance of informed consent and realistic expectations

This conversation does not dismiss patient experiences, nor does it ignore the life-saving role buprenorphine has played in recovery. Instead, it brings nuance to a complex issue—balancing clinical evidence with lived experience.

Whether you are a provider, patient, policymaker, or simply interested in addiction medicine, this episode offers thoughtful insight into efficacy, expectations, and long-term outcomes.

More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=buprenorphine